🇺🇸 FDA
Patent

US 12171786

Use of mesenchymal stem cells for the treatment of inflammation

granted A61KA61K2035/124A61K35/28

Quick answer

US patent 12171786 (Use of mesenchymal stem cells for the treatment of inflammation) held by The Regents of the University of California expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2035/124, A61K35/28